ID   ZNF24_HUMAN             Reviewed;         368 AA.
AC   P17028; O14754; Q53YE4; Q6ICR5; Q8IZN4;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 4.
DT   28-JUN-2023, entry version 235.
DE   RecName: Full=Zinc finger protein 24;
DE   AltName: Full=Retinoic acid suppression protein A;
DE            Short=RSG-A;
DE   AltName: Full=Zinc finger and SCAN domain-containing protein 3;
DE   AltName: Full=Zinc finger protein 191;
DE   AltName: Full=Zinc finger protein KOX17;
GN   Name=ZNF24; Synonyms=KOX17, ZNF191, ZSCAN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   SER-220.
RC   TISSUE=Liver;
RA   Shi S., Yu L.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND VARIANT SER-220.
RC   TISSUE=Bone marrow;
RX   PubMed=10585455; DOI=10.1074/jbc.274.50.35741;
RA   Han Z.-G., Zhang Q.-H., Ye M., Kan L.-X., Gu B.-W., He K.-L., Shi S.-L.,
RA   Zhou J., Fu G., Mao M., Chen S.-J., Yu L., Chen Z.;
RT   "Molecular cloning of six novel Kruppel-like zinc finger genes from
RT   hematopoietic cells and identification of a novel transregulatory domain
RT   KRNB.";
RL   J. Biol. Chem. 274:35741-35748(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-220.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-220.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-220.
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 319-362 (ISOFORM 1).
RC   TISSUE=Lymphoid tissue;
RX   PubMed=2288909;
RA   Thiesen H.-J.;
RT   "Multiple genes encoding zinc finger domains are expressed in human T
RT   cells.";
RL   New Biol. 2:363-374(1990).
RN   [9]
RP   SUMOYLATION.
RX   PubMed=15561718; DOI=10.1074/jbc.m411718200;
RA   Gocke C.B., Yu H., Kang J.;
RT   "Systematic identification and analysis of mammalian small ubiquitin-like
RT   modifier substrates.";
RL   J. Biol. Chem. 280:5004-5012(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-335, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142 AND SER-274, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-286 AND ARG-290.
RX   PubMed=24224020; DOI=10.1371/journal.pone.0079910;
RA   Li J.Z., Chen X., Gong X.L., Hu H.Y., Shi D., Lu Y.M., Qiu L., Lu F.,
RA   Hu Z.L., Zhang J.P.;
RT   "Identification of a functional nuclear localization signal mediating
RT   nuclear import of the zinc finger transcription factor ZNF24.";
RL   PLoS ONE 8:E79910-E79910(2013).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-27, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-27, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-27, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-27 AND LYS-277, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-22; LYS-27; LYS-147; LYS-177;
RP   LYS-236; LYS-277; LYS-286; LYS-361 AND LYS-367, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [22]
RP   STRUCTURE BY NMR OF 272-330.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the C2H2 type zinc finger domain of human zinc
RT   finger protein 24.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Transcription factor required for myelination of
CC       differentiated oligodendrocytes. Required for the conversion of
CC       oligodendrocytes from the premyelinating to the myelinating state. In
CC       the developing central nervous system (CNS), involved in the
CC       maintenance in the progenitor stage by promoting the cell cycle.
CC       Specifically binds to the 5'-TCAT-3' DNA sequence (By similarity). Has
CC       transcription repressor activity in vitro. {ECO:0000250,
CC       ECO:0000269|PubMed:10585455}.
CC   -!- INTERACTION:
CC       P17028; P51693: APLP1; NbExp=2; IntAct=EBI-707773, EBI-74648;
CC       P17028; P02649: APOE; NbExp=3; IntAct=EBI-707773, EBI-1222467;
CC       P17028; P05067: APP; NbExp=3; IntAct=EBI-707773, EBI-77613;
CC       P17028; P26196: DDX6; NbExp=3; IntAct=EBI-707773, EBI-351257;
CC       P17028; Q86Y13: DZIP3; NbExp=5; IntAct=EBI-707773, EBI-948630;
CC       P17028; Q3B820: FAM161A; NbExp=3; IntAct=EBI-707773, EBI-719941;
CC       P17028; P25800: LMO1; NbExp=5; IntAct=EBI-707773, EBI-8639312;
CC       P17028; P25791: LMO2; NbExp=4; IntAct=EBI-707773, EBI-739696;
CC       P17028; P25791-3: LMO2; NbExp=3; IntAct=EBI-707773, EBI-11959475;
CC       P17028; Q9BXW4: MAP1LC3C; NbExp=3; IntAct=EBI-707773, EBI-2603996;
CC       P17028; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-707773, EBI-10172526;
CC       P17028; Q9HC98-4: NEK6; NbExp=3; IntAct=EBI-707773, EBI-11750983;
CC       P17028; Q96JS3: PGBD1; NbExp=8; IntAct=EBI-707773, EBI-10290053;
CC       P17028; Q8WWY3: PRPF31; NbExp=3; IntAct=EBI-707773, EBI-1567797;
CC       P17028; P57086: SCAND1; NbExp=7; IntAct=EBI-707773, EBI-745846;
CC       P17028; Q9Y4C2: TCAF1; NbExp=3; IntAct=EBI-707773, EBI-750484;
CC       P17028; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-707773, EBI-10180829;
CC       P17028; P13994: YJU2B; NbExp=7; IntAct=EBI-707773, EBI-716093;
CC       P17028; Q8N5A5-2: ZGPAT; NbExp=3; IntAct=EBI-707773, EBI-10183064;
CC       P17028; Q969J2: ZKSCAN4; NbExp=5; IntAct=EBI-707773, EBI-2818641;
CC       P17028; P49910: ZNF165; NbExp=3; IntAct=EBI-707773, EBI-741694;
CC       P17028; Q15697-2: ZNF174; NbExp=4; IntAct=EBI-707773, EBI-11158827;
CC       P17028; Q9UNY5: ZNF232; NbExp=3; IntAct=EBI-707773, EBI-749023;
CC       P17028; P17028: ZNF24; NbExp=4; IntAct=EBI-707773, EBI-707773;
CC       P17028; Q96N95-3: ZNF396; NbExp=5; IntAct=EBI-707773, EBI-12328453;
CC       P17028; Q86VK4-3: ZNF410; NbExp=3; IntAct=EBI-707773, EBI-11741890;
CC       P17028; Q8N0Y2-2: ZNF444; NbExp=6; IntAct=EBI-707773, EBI-12010736;
CC       P17028; Q9NWS9: ZNF446; NbExp=4; IntAct=EBI-707773, EBI-3925851;
CC       P17028; Q9NWS9-2: ZNF446; NbExp=13; IntAct=EBI-707773, EBI-740232;
CC       P17028; Q6P088: ZNF483; NbExp=3; IntAct=EBI-707773, EBI-10196963;
CC       P17028; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-707773, EBI-4395669;
CC       P17028; O43309: ZSCAN12; NbExp=3; IntAct=EBI-707773, EBI-1210440;
CC       P17028; Q9H4T2: ZSCAN16; NbExp=3; IntAct=EBI-707773, EBI-723596;
CC       P17028; Q9Y5A6: ZSCAN21; NbExp=6; IntAct=EBI-707773, EBI-10281938;
CC       P17028; P10073: ZSCAN22; NbExp=6; IntAct=EBI-707773, EBI-10178224;
CC       P17028; Q3MJ62: ZSCAN23; NbExp=3; IntAct=EBI-707773, EBI-5667532;
CC       P17028; Q9NX65: ZSCAN32; NbExp=9; IntAct=EBI-707773, EBI-739949;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00187,
CC       ECO:0000269|PubMed:24224020}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P17028-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P17028-2; Sequence=VSP_039219, VSP_039220;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues except in heart.
CC   -!- PTM: Sumoylated. {ECO:0000269|PubMed:15561718}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U68536; AAB37275.1; -; mRNA.
DR   EMBL; AF016052; AAB70216.1; -; Genomic_DNA.
DR   EMBL; AF542097; AAN40767.1; -; mRNA.
DR   EMBL; AF038964; AAD19827.1; -; mRNA.
DR   EMBL; AK291246; BAF83935.1; -; mRNA.
DR   EMBL; BT006658; AAP35304.1; -; mRNA.
DR   EMBL; CR450328; CAG29324.1; -; mRNA.
DR   EMBL; AC116447; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471088; EAX01348.1; -; Genomic_DNA.
DR   EMBL; CH471088; EAX01349.1; -; Genomic_DNA.
DR   EMBL; BC003566; AAH03566.1; -; mRNA.
DR   EMBL; BC016801; AAH16801.1; -; mRNA.
DR   EMBL; X52348; CAA36574.1; -; mRNA.
DR   CCDS; CCDS11912.1; -. [P17028-1]
DR   CCDS; CCDS77175.1; -. [P17028-2]
DR   PIR; I37956; I37956.
DR   RefSeq; NP_001295052.1; NM_001308123.1. [P17028-2]
DR   RefSeq; NP_008896.2; NM_006965.3. [P17028-1]
DR   RefSeq; XP_005258398.1; XM_005258341.3.
DR   PDB; 1X6E; NMR; -; A=272-330.
DR   PDB; 3LHR; X-ray; 1.90 A; A/B=46-136.
DR   PDBsum; 1X6E; -.
DR   PDBsum; 3LHR; -.
DR   AlphaFoldDB; P17028; -.
DR   SMR; P17028; -.
DR   BioGRID; 113403; 153.
DR   IntAct; P17028; 90.
DR   MINT; P17028; -.
DR   STRING; 9606.ENSP00000261332; -.
DR   iPTMnet; P17028; -.
DR   PhosphoSitePlus; P17028; -.
DR   SwissPalm; P17028; -.
DR   BioMuta; ZNF24; -.
DR   DMDM; 160376173; -.
DR   EPD; P17028; -.
DR   jPOST; P17028; -.
DR   MassIVE; P17028; -.
DR   MaxQB; P17028; -.
DR   PaxDb; P17028; -.
DR   PeptideAtlas; P17028; -.
DR   ProteomicsDB; 53429; -. [P17028-1]
DR   ProteomicsDB; 53430; -. [P17028-2]
DR   Antibodypedia; 8576; 296 antibodies from 32 providers.
DR   DNASU; 7572; -.
DR   Ensembl; ENST00000261332.11; ENSP00000261332.5; ENSG00000172466.16. [P17028-1]
DR   Ensembl; ENST00000399061.3; ENSP00000382015.2; ENSG00000172466.16. [P17028-1]
DR   Ensembl; ENST00000589881.5; ENSP00000467655.1; ENSG00000172466.16. [P17028-2]
DR   GeneID; 7572; -.
DR   KEGG; hsa:7572; -.
DR   MANE-Select; ENST00000261332.11; ENSP00000261332.5; NM_006965.4; NP_008896.2.
DR   UCSC; uc002kys.3; human. [P17028-1]
DR   AGR; HGNC:13032; -.
DR   CTD; 7572; -.
DR   DisGeNET; 7572; -.
DR   GeneCards; ZNF24; -.
DR   HGNC; HGNC:13032; ZNF24.
DR   HPA; ENSG00000172466; Low tissue specificity.
DR   MIM; 194534; gene.
DR   neXtProt; NX_P17028; -.
DR   OpenTargets; ENSG00000172466; -.
DR   PharmGKB; PA37610; -.
DR   VEuPathDB; HostDB:ENSG00000172466; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000161396; -.
DR   HOGENOM; CLU_002678_49_3_1; -.
DR   InParanoid; P17028; -.
DR   OMA; VAQIFKY; -.
DR   OrthoDB; 4330481at2759; -.
DR   PhylomeDB; P17028; -.
DR   TreeFam; TF338304; -.
DR   PathwayCommons; P17028; -.
DR   SignaLink; P17028; -.
DR   BioGRID-ORCS; 7572; 82 hits in 1180 CRISPR screens.
DR   ChiTaRS; ZNF24; human.
DR   EvolutionaryTrace; P17028; -.
DR   GeneWiki; ZNF24; -.
DR   GenomeRNAi; 7572; -.
DR   Pharos; P17028; Tbio.
DR   PRO; PR:P17028; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; P17028; protein.
DR   Bgee; ENSG00000172466; Expressed in medial globus pallidus and 213 other tissues.
DR   ExpressionAtlas; P17028; baseline and differential.
DR   Genevisible; P17028; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0042552; P:myelination; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07936; SCAN; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 4.
DR   Gene3D; 1.10.4020.10; DNA breaking-rejoining enzymes; 1.
DR   InterPro; IPR003309; SCAN_dom.
DR   InterPro; IPR038269; SCAN_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR45935; PROTEIN ZBED8-RELATED; 1.
DR   PANTHER; PTHR45935:SF15; SCAN DOMAIN-CONTAINING PROTEIN 3; 1.
DR   Pfam; PF02023; SCAN; 1.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   SMART; SM00431; SCAN; 1.
DR   SMART; SM00355; ZnF_C2H2; 4.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 3.
DR   SUPFAM; SSF47353; Retrovirus capsid dimerization domain-like; 1.
DR   PROSITE; PS50804; SCAN_BOX; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..368
FT                   /note="Zinc finger protein 24"
FT                   /id="PRO_0000047352"
FT   DOMAIN          52..134
FT                   /note="SCAN box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00187"
FT   ZN_FING         251..273
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         279..301
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         307..329
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         335..357
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          251..301
FT                   /note="Necessary and sufficient for nuclear localization"
FT   MOD_RES         132
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         274
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         335
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        27
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        27
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:25218447, ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733"
FT   CROSSLNK        147
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        177
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        236
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        277
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        286
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        361
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        367
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         190..193
FT                   /note="DDDG -> VIIP (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_039219"
FT   VAR_SEQ         194..368
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_039220"
FT   VARIANT         220
FT                   /note="N -> S (in dbSNP:rs2032729)"
FT                   /evidence="ECO:0000269|PubMed:10585455,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|Ref.1, ECO:0000269|Ref.4"
FT                   /id="VAR_012017"
FT   VARIANT         331
FT                   /note="G -> W (in dbSNP:rs3568)"
FT                   /id="VAR_012018"
FT   MUTAGEN         286
FT                   /note="K->A: Partial cytoplasmic accumulation."
FT                   /evidence="ECO:0000269|PubMed:24224020"
FT   MUTAGEN         290
FT                   /note="R->A: Partial cytoplasmic accumulation."
FT                   /evidence="ECO:0000269|PubMed:24224020"
FT   CONFLICT        367
FT                   /note="K -> E (in Ref. 1; AAB37275 and 4; CAG29324)"
FT                   /evidence="ECO:0000305"
FT   HELIX           47..57
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   HELIX           60..62
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   HELIX           66..81
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   TURN            83..85
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   HELIX           88..102
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   HELIX           106..114
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   HELIX           120..134
FT                   /evidence="ECO:0007829|PDB:3LHR"
FT   TURN            272..275
FT                   /evidence="ECO:0007829|PDB:1X6E"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:1X6E"
FT   STRAND          287..290
FT                   /evidence="ECO:0007829|PDB:1X6E"
FT   HELIX           291..299
FT                   /evidence="ECO:0007829|PDB:1X6E"
FT   HELIX           300..302
FT                   /evidence="ECO:0007829|PDB:1X6E"
FT   STRAND          310..312
FT                   /evidence="ECO:0007829|PDB:1X6E"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:1X6E"
FT   HELIX           319..330
FT                   /evidence="ECO:0007829|PDB:1X6E"
SQ   SEQUENCE   368 AA;  42155 MW;  B890EDC512493E0E CRC64;
     MSAQSVEEDS ILIIPTPDEE EKILRVKLEE DPDGEEGSSI PWNHLPDPEI FRQRFRQFGY
     QDSPGPREAV SQLRELCRLW LRPETHTKEQ ILELVVLEQF VAILPKELQT WVRDHHPENG
     EEAVTVLEDL ESELDDPGQP VSLRRRKREV LVEDMVSQEE AQGLPSSELD AVENQLKWAS
     WELHSLRHCD DDGRTENGAL APKQELPSAL ESHEVPGTLN MGVPQIFKYG ETCFPKGRFE
     RKRNPSRKKQ HICDECGKHF SQGSALILHQ RIHSGEKPYG CVECGKAFSR SSILVQHQRV
     HTGEKPYKCL ECGKAFSQNS GLINHQRIHT GEKPYECVQC GKSYSQSSNL FRHQRRHNAE
     KLLNVVKV
//
